Evidence map›Paper›PMID 39448358›Full record

ArticleJournal of geriatric oncology2025

Smartphone application for longitudinal home gait speed measurement in older adults with blood cancers: A feasibility and acceptability study.

Pei-An Lee, Clark DuMontier, Nicholas Groblewski, Wanting Yu, Junhong Zhou, Tammy Hshieh, Dae Kim, Tom Travison, Jane Driver, On-Yee Lo and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of geriatric oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Pei-An LeeHebrew SeniorLife, Harvard Medical School, Boston, MA, United States of America; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States of America.
Clark DuMontierVA Boston Healthcare System, Harvard Medical School, Boston, MA, United States of America; Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States of America; Dana-Farber Cancer Institute, Boston, MA, United States of America.
Nicholas GroblewskiVA Boston Healthcare System, Harvard Medical School, Boston, MA, United States of America; Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States of America; Dana-Farber Cancer Institute, Boston, MA, United States of America.
Wanting YuHebrew SeniorLife, Harvard Medical School, Boston, MA, United States of America.
Junhong ZhouHebrew SeniorLife, Harvard Medical School, Boston, MA, United States of America; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States of America.
Tammy HshiehBrigham and Women's Hospital, Harvard Medical School, Boston, MA, United States of America; Dana-Farber Cancer Institute, Boston, MA, United States of America.
Dae KimHebrew SeniorLife, Harvard Medical School, Boston, MA, United States of America; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States of America.
Tom TravisonHebrew SeniorLife, Harvard Medical School, Boston, MA, United States of America; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States of America.
Jane DriverVA Boston Healthcare System, Harvard Medical School, Boston, MA, United States of America; Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States of America.
On-Yee LoHebrew SeniorLife, Harvard Medical School, Boston, MA, United States of America; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States of America.
Brad ManorHebrew SeniorLife, Harvard Medical School, Boston, MA, United States of America; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States of America.
Gregory AbelBrigham and Women's Hospital, Harvard Medical School, Boston, MA, United States of America; Dana-Farber Cancer Institute, Boston, MA, United States of America. Electronic address: Gregory_Abel@dfci.HARVARD.EDU.

Funding

Trageting the Multiple Myeloma EpigenomeP50CA100707 · NCI · DANA-FARBER CANCER INSTITUTE · PI ANDERSON, KENNETH C., MUNSHI, NIKHIL C. · 2003 to 2023
$45.0M
TUFTS--FIELDINGP30AG031679 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI Thomas Glenn Travison · 2008 to 2026
$23.9M
Mid-Career Mentoring Award For Patient-Oriented Research in Frailty and Health OutcomesK24AG073527 · NIA · HEBREW REHABILITATION CENTER FOR AGED · PI Dae Hyun Kim · 2022 to 2026
$862k
Modulating brain networks to reduce gait variability in older adults at risk of fallingK01AG075252 · NIA · HEBREW REHABILITATION CENTER FOR AGED · PI CARRETIE, SABRINA, LO, ON-YEE AMY · 2022 to 2024
$362k
NCI NIH HHS P50 CA100707NIA NIH HHS K01 AG075252NIA NIH HHS K24 AG073527NIA NIH HHS P30 AG031679
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Blood cancerFour-meter walking testGait speedSmartphone gait application

Identifiers

PMID39448358
PMCPMC11890937

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.